April 14 - 18, 2018
McCormick Place North/South
Chicago, Illinois, USA
Abstract submission deadline: Wednesday, January 24
Advance registration deadline: Monday, February 5
Late-Breaking Abstracts The extended deadline for late-breaking abstracts was 10 a.m. U.S. ET, Wednesday, Jan. 24, 2018. Abstracts detailing highly significant and timely findings in any area of cancer research that were not available at the time of the regular abstract deadline may be submitted for consideration as a late-breaking abstract. Only those abstracts that are deemed to be of high scientific priority will be accepted.
A special subcommittee of the Program Committee will evaluate the merit of late-breaking abstracts. The online submitter will re-open to accommodate late-breaking abstract submissions beginning Wednesday, Jan. 3, 2018. Each late-breaking abstract must be sponsored by an AACR member. Abstract submission fees and sponsorship regulations also apply to late-breaking abstracts.
Clinical Trials Abstracts
All abstracts describing clinical trials (including placeholder abstracts) should be submitted as late-breaking abstracts. The extended deadline for clinical trials abstracts was 10 a.m. U.S. ET, Wednesday, Jan. 24, 2018. Final data for placeholder abstracts are due
Friday, Feb. 23, 2018. For details, visit the
Clinical Trials webpage.
Deadline for Withdrawal of AbstractsThe AACR cannot comply with any request for withdrawal of an abstract that will delay the publication of the
Proceedings. However, requests to withdraw abstracts will be accepted through
Friday, Feb. 16, 2018. Requests to withdraw late-breaking abstracts will be accepted through
Friday, March 9, 2018. Withdrawal requests must be sent by email to
firstname.lastname@example.org. Withdrawal requests must include the abstract control number and title as well as an explanation of the reason for withdrawal.
Notifications of Abstract StatusRegular abstract status notifications will be emailed to the presenting authors on
Tuesday, Jan. 30, 2018. Late-Breaking and Clinical Trials abstract notifications
will be emailed to the presenting authors on Wednesday, Feb. 28, 2018.
Online Publication of AbstractsAbstracts that have been accepted for presentation are scheduled to be posted to the AACR Online Itinerary Planner no earlier than 4:30 p.m. U.S. ET on Wednesday, March 14, 2018. Abstracts selected for inclusion in the AACR Press Program will be made available at a later date to be determined.
Presentation of Proffered Papers at the AACR Annual MeetingEvery proffered abstract that has been accepted for publication in the
Proceedings must have a corresponding presentation at the meeting. Specifically, the author listed as the presenter for an accepted proffered paper must attend the corresponding session to discuss in detail the research outlined in the published abstract, according to the specific guidelines of the session. If, due to unforeseen circumstances, the designated presenter is unavailable to attend the session to present the paper, he or she must contact the AACR Program Development Department to designate a coauthor to serve as the presenter. If no abstract authors are available to present the data, they must withdraw the abstract immediately by contacting the AACR Program Development Department at 215-440-9300 or
Failure to comply with these regulations pertaining to abstract presentation may result in actions including, but not limited to:
Top of page